Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 7, 2000
Environmental stress and psychiatric illnessO Agid, Y Kohn, B LererThe Journal of Clinical Psychiatry|April 18, 2001
Triiodothyronine augmentation of selective serotonin reuptake inhibitors in posttraumatic stress disorderO Agid, A Y Shalev, B LererActa Psychiatrica Scandinavica|May 23, 2014
Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophreniaG Fervaha, G Foussias, O Agid, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|March 18, 2014
Impact of primary negative symptoms on functional outcomes in schizophreniaG Fervaha, G Foussias, O Agid, et al.Acta Psychiatrica Scandinavica|July 7, 2020
Adherence to clozapine vs. other antipsychotics in schizophreniaH Takeuchi, C Borlido, M Sanches, et al.Schizophrenia Research|July 21, 2011
Prediction of longitudinal functional outcomes in schizophrenia: the impact of baseline motivational deficitsG Foussias, S Mann, K K Zakzanis, et al.Comprehensive Psychiatry|September 30, 2000
The impact of parental death versus separation from parents on the mental health of Israeli adolescentsL Canetti, E Bachar, O Bonne, et al.Schizophrenia Research|May 27, 2015
Motivated to do well: an examination of the relationships between motivation, effort, and cognitive performance in schizophreniaG Foussias, I Siddiqui, G Fervaha, et al.Acta Psychiatrica Scandinavica|May 17, 2016
Clozapine administration in clinical practice: once-daily versus divided dosingH Takeuchi, V Powell, S Geisler, et al.Expert Opinion on Drug Safety|May 22, 2016
Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and useG Remington, J Lee, O Agid, et al.Pageof 2